CFO
ALAB icon

Callan Family Office’s Astera Labs ALAB Stock Holding History

Callan Family Office’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
2,830
+57
+2% +$15.1K 0.03% 510
2026
Q1 		$304K Sell
2,773
-414
-13% -$59K 0.01% 928
2025
Q4 		$530K Buy
3,187
+445
+16% +$74.4K 0.01% 767
2025
Q3 		$537K Sell
2,742
-139
-5% -$22.9K 0.02% 509
2025
Q2 		$261K Buy
+2,881
New +$228K 0.01% 809

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Callan Family Office's ALAB Position: Q2 2026 in Review

Callan Family Office increased its Astera Labs (ALAB) stake by 2.1% in Q2 2026, buying an estimated $15.1K and bringing the position to 2,830 shares worth $1.37M. The position accounts for 0.03% of the portfolio, ranked #510.

Callan Family Office first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Callan Family Office held 2,830 shares of Astera Labs worth $1.37M as of Q2 2026.
  • Callan Family Office bought 57 Astera Labs shares in Q2 2026, an estimated $15.1K.
  • Astera Labs made up 0.03% of Callan Family Office's portfolio in Q2 2026, its #510 holding.
  • Callan Family Office first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.